US-20260124403-A1 - ALERTS SYSTEM FOR INJECTABLE ADMINISTRATION COMPLIANCE PLATFORM

US20260124403A1US 20260124403 A1US20260124403 A1US 20260124403A1US-20260124403-A1

Abstract

A method, computer program product, and computer system for a platform for managing injectable medication administration alerts. The platform may include: a server configured to receive administration data from an intelligent injection device, a database configured to store treatment schedules, an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules, and an alerts module configured to: generate and send notifications based on injection event categorization, deliver alerts related to health, biometrics, medications and injections, provide visual and audible outputs regarding injection administration, and warn users about detected behaviors that may negatively impact treatment.

Inventors

Jeremy Corbett

Assignees

DATADOSE, LLC

Dates

Publication Date: 20260507
Application Date: 20250118

Claims (20)

1 . A platform for managing injectable medication administration alerts, comprising: a server configured to receive administration data from an intelligent injection device; a database configured to store treatment schedules; an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules; and an alerts module configured to: generate and send notifications based on injection event categorization, deliver alerts related to health, biometrics, medications and injections, provide visual and audible outputs regarding injection administration, and warn users about detected behaviors that may negatively impact treatment.
2 . The platform of claim 1 , wherein the alerts module is configurable by a user to customize notification preferences and alert delivery methods.
3 . The platform of claim 1 , wherein the alerts module is configurable by a healthcare provider to set alerts based on prescribed treatment schedules and medical determinations.
4 . The platform of claim 1 , wherein the alerts module is automatically configured based on a prescribed injectable administration plan stored in the treatment schedule database.
5 . The platform of claim 4 , wherein the alerts module is configured to send a signal to a wearable device to display an alert to a patient indicating that a self-injection is due according to an injection schedule.
6 . The platform of claim 1 , wherein the alerts module is configured to generate warnings when improper use of an intelligent injection device is detected by the artificial intelligence module.
7 . The platform of claim 6 , wherein the alerts module is configured to generate alerts regarding potential adverse medication interactions based on patient data and treatment schedules.
8 . The platform of claim 1 , wherein the alerts module is configured to generate notifications when administration data indicates incomplete or non-compliant injection events.
9 . The platform of claim 8 , wherein the alerts module is configured to generate warnings when temperature data from the intelligent injection device indicates potential degradation of medication during transport or storage.
10 . A platform for real-time monitoring of injectable medication administration, comprising: a server configured to receive administration data from a wireless module associated with an intelligent injection device, wherein the administration data includes at least one of: an injection device ID, a drug ID, a patient ID, a potency value, an administration completion flag, a timestamp, and temperature data; a database configured to store treatment schedules; an artificial intelligence module configured to: calculate a compliance score for an injection event based on conformance of the administration data to at least one criterion of a treatment schedule, and compare the compliance score to a compliance threshold metric to categorize the injection event; and a monitoring system configured to track user compliance with prescribed medication regimens.
11 . The platform of claim 10 , wherein the artificial intelligence module is configured to detect behaviors that may negatively impact treatment compliance and trigger alerts to generate appropriate warnings.
12 . The platform of claim 11 , wherein the platform is configured to send notifications to healthcare providers when patient non-compliance is detected.
13 . The platform of claim 10 , wherein the platform is configured to generate alerts based on real-time monitoring of injection events.
14 . The platform of claim 10 , wherein the platform is integrated with at least one of: IoT devices configured to collect environmental data, wearable devices configured to collect patient biometric data, and electronic medical record systems configured to store patient treatment data.
15 . The platform of claim 14 , wherein the platform includes a verification module configured to: validate authenticity of the intelligent injection device, verify user identity prior to injection administration, and prevent medication errors in institutional settings.
16 . The platform of claim 15 , wherein the platform includes a custody and supply chain management system configured to: track medications from manufacturer to patient, ensure medications are securely managed, reduce risk of errors and fraud, and enhance patient safety.
17 . The platform of claim 10 , wherein the artificial intelligence module is further configured to determine whether the intelligent injection device was fraudulently used or wasted based on the administration data.
18 . The platform of claim 17 , wherein the platform is configured to automatically populate electronic medical record fields with the administration data.
19 . The platform of claim 10 , wherein the platform is configured to process the administration data to make at least one of: medical determinations, insurance coverage determinations, and manufacturing determinations.
20 . A method for managing injectable medication administration alerts, comprising: receiving administration data from an intelligent injection device; comparing the administration data to stored treatment schedules; generating alerts based on the comparison of administration data to treatment schedules; delivering the alerts through at least one of: visual displays, audible outputs, and wearable devices; and configuring alert preferences based on user input and treatment requirements.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a continuation of U.S. patent application Ser. No. 19/031,031, filed on Jan. 17, 2025, which claims the benefit of U.S. provisional application no. 63/715,505, filed on Nov. 1, 2024, which is hereby incorporated by reference in its entirety. FIELD The present disclosure relates generally to a management platform for injection devices, such as syringes, and, more particularly, to data reporting regarding administration completion of an injectable pharmaceutical. BACKGROUND Understanding administration of drugs and their interaction in the healthcare ecosystem are important in delivering beneficial patient care. Applicant appreciates that regular pharmaceutical therapy and a need for real time data management related to both timing of and compliance in dosing bundled with increased information sharing across the care continuum can provide valuable insight for improving care and, in turn, reducing fraud, waste, and abuse. SUMMARY In some aspects, the techniques described herein relate to a platform for managing injectable medication administration alerts, including: a server configured to receive administration data from an intelligent injection device; a database configured to store treatment schedules; an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules; and an alerts module configured to: generate and send notifications based on injection event categorization, deliver alerts related to health, biometrics, medications and injections, provide visual and audible outputs regarding injection administration, and warn users about detected behaviors that may negatively impact treatment. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is configurable by a user to customize notification preferences and alert delivery methods. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is configurable by a healthcare provider to set alerts based on prescribed treatment schedules and medical determinations. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is automatically configured based on a prescribed injectable administration plan stored in the treatment schedule database. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is configured to send a signal to a wearable device to display an alert to a patient indicating that a self-injection is due according to an injection schedule. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is configured to generate warnings when improper use of an intelligent injection device is detected by the artificial intelligence module. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is configured to generate alerts regarding potential adverse medication interactions based on patient data and treatment schedules. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is configured to generate notifications when administration data indicates incomplete or non-compliant injection events. In some aspects, the techniques described herein relate to a platform, wherein the alerts module is configured to generate warnings when temperature data from the intelligent injection device indicates potential degradation of medication during transport or storage. In some aspects, the techniques described herein relate to a platform for real-time monitoring of injectable medication administration, including: a server configured to receive administration data from a wireless module associated with an intelligent injection device, wherein the administration data includes at least one of: an injection device ID, a drug ID, a patient ID, a potency value, an administration completion flag, a timestamp, and temperature data; a database configured to store treatment schedules; an artificial intelligence module configured to: calculate a compliance score for an injection event based on conformance of the administration data to at least one criterion of a treatment schedule, and compare the compliance score to a compliance threshold metric to categorize the injection event; and a monitoring system configured to track user compliance with prescribed medication regimens. In some aspects, the techniques described herein relate to a platform, wherein the artificial intelligence module is configured to detect behaviors that may negatively impact treatment compliance and trigger alerts to generate appropriate warnings. In some aspects, the techniques described herein relate to a platform, wherein the platform is configured to send notifications to healthcare providers when patient non-compliance is detected. In some aspects, the techniques described herein relate to a platform,